Abstracts
Objective: To study the regulation of Fas receptor (Fas)/Fas ligand (FasL) expression by IFN-γ in cholangiocarcinoma cell lines. Methods: We studied the expressions of Fas and FasL gene in the human cholangiocarcinoma cell line QBC939 by RT-PCR, Western blot, and immunohistochemistry and their apoptosis effects on human T cell line Jurkat cell. At the same time, we investigated the regulative effect of IFN-γ on them. Results: Fas, FasL mRNA and protein were expressed by cholangiocarcinoma cells. We also found IFN-γ could up-regulate the expressions of these two genes. However, IFN-γ could also down-regulate the ability of them to make Jurkat cells apoptotic. With the increasing of dosage and time, the effect was enhanced. Conclusion: IFN-γ could regulate the expression of Fas and FasL in cholangiocarcinoma cells, and might influence the ability of cholangiocarcinoma to regulate immune escape. This study provides new theoretical basis for immunological therapy of cholangiocarcinoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Jones BA, Gores GJ. Hepatobiliary malignancy [J]. Clin Liver Dis 1998; 2:437–49.
O’Connell J, O’Sullivan GC, Collins JK, et al. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand [J]. J Exp Med 1996; 184:1075–82.
Li DJ, Wang SG, Chen CH, et al. Effects of nm23-H1 gene transfection on proliferation of human QBC939 cholangiocarcinoma cell line [J]. Chin J Exp Srug 2004; 21:948–50.
Que FG, Phan VA, Phan VH, et al. Cholangiocarcinomas express Fas ligand and disable the Fas receptor [J]. Hepatology 1999; 30:1398–404.
Shimonishi T, Isse K, Shibata F, et al. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance [J]. Hepatology 2000;32:761–9.
von Bernstorff W, Spanjaard RA, Chan AK, et al. Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/ CD95) receptors and aberrant expression of functional Fas ligand [J]. Surgery 1999; 125:73–84.
von Reyher U, Strater J, Kittstein W, et al. Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis [J]. Cancer Res 1998; 58:526–34.
Lebel M, Bertrand R, Mes-Masson AM. Decreased Fas antigen receptor expression in testicular tumor cell lines derived from polyomavirus large T-antigen transgenic mice [J]. Oncogene 1996; 12:1127–35.
Author information
Authors and Affiliations
Corresponding author
Additional information
Biography: Li Zi-yu (1971–), male, postdoctoral fellow of Peking University, attending surgeon of Beijing Cancer Hospital, majors in surgical oncology.
Rights and permissions
About this article
Cite this article
Li, Zy., Zhang, Lh. & Ji, Jf. IFN-γ regulates Fas/FasL expression in cholangio carcinoma cells. Chin. J. Cancer Res. 17, 40–43 (2005). https://doi.org/10.1007/s11670-005-0008-3
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11670-005-0008-3